# Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation

> **NCT07447297** · NA · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 520 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Diseases of the Circulatory System
- Atrial Flutter

## Interventions

- **DRUG:** early rhythm control group
- **PROCEDURE:** cardioversion, catheter ablation
- **OTHER:** general control

## Key facts

- **NCT ID:** NCT07447297
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-02
- **Primary completion:** 2027-12-15
- **Final completion:** 2029-12-31
- **Target enrollment:** 520 (ESTIMATED)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07447297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07447297, "Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07447297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*